News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
GeNeuro and Verily Collaborate to Progress Long-COVID Research
Friday, October 20, 2023GeNeuro a biopharmaceutical company listed on Euronext Paris under the symbol GNRO has announced a strategic collaboration with Verily a precision health technology company within Alphabet The aim of this partnership is to investigate biomarkers asso...
ERS Genomics Limited and Syngene International Successfully Conclude Licensing Agreement
Thursday, October 19, 2023ERS Genomics cofounded by Dr Emmanuelle Charpentier who was awarded the Nobel Prize in Chemistry in for her pioneering work in the field of CRISPRCas provides access
Stuart Therapeutics Enters into Exclusive Worldwide Licensing Agreement with Glaukos Corporation
Thursday, October 19, 2023Stuart Therapeutics Inc has announced a licensing agreement with Glaukos Corporation granting Glaukos exclusive global rights to develop and commercialize Stuarts proprietary drug candidate ST
Avanzanite Bioscience Expands Collaboration With Advicenne to Include Additional European Nations
Wednesday, October 18, 2023Avanzanite Bioscience BV has announced an expansion of its commercial partnership with Advicenne a specialty pharmaceutical company based in Paris for the distribution of Sibnayal
Cimeio Therapeutics and the University of Pennsylvania Announce Collaboration for Preclinical Studies on CD45 Universal CAR T Cell Therapy in Blood and Bone Marrow Cancers
Tuesday, October 17, 2023Cimeio Therapeutics has recently announced a new preclinical research partnership with Dr Saar Gill an associate professor of medicine with both MD and PhD qualifications working at the Perelman School of Medicine
SOTIO Expands ADC Pipeline Through Licensing Agreement With Synaffix
Monday, October 16, 2023Synaffix BV a company now part of Lonza focuses on advancing its clinicalstage platform technology for the development of antibodydrug conjugates ADCs with a strong therapeutic index They have entered into a licensing agreement
Epimab Biotherapeutics and Almirall Announce a License Agreement for Bispecific Antibodies
Saturday, October 14, 2023EpimAb Biotherapeutics a clinicalstage biopharmaceutical company specializing in the development of multispecific antibodies
Mimivax Has Been Granted Fast Track Designation by the Fda for Survaxm in the Management of Newly Diagnosed Glioblastoma
Friday, October 13, 2023MimiVax a biotechnology company specializing in glioblastoma vaccine therapy development recently announced that the United States Food and Drug Administration FDA
AGC Biologics Successfully Expands its pDNA and mRNA Production Lines in Heidelberg
Friday, October 13, 2023AGC Biologics a prominent global Contract Development and Manufacturing Organization CDMO specializing in the biopharmaceutical industry
Kanvas Biosciences Enhances Operations Through Acquisition of Federation Bio Assets to Advance Research, Development, and Production of Microbiome-based Therapeutics
Thursday, October 12, 2023Kanvas Biosciences a company specializing in microbiome mapping technology has announced its acquisition of two active therapeutics programs a microbial library and intellectual property from Federation Bio a manufacturer of live biotherapeutics prod...
